Literature DB >> 2722687

Synthesis and biological activity of analogues of diazaquinomycin A, a new thymidylate synthase inhibitor.

K Tsuzuki1, T Yokozuka, M Murata, H Tanaka, S Omura.   

Abstract

Diazaquinomycin A (1), a new thymidylate (TMP) synthase inhibitor, is poorly soluble in various solvents and exhibits no antitumor activity, while a series of the analogues prepared from 1 are more soluble in water and chloroform than 1, and some of them exhibit antitumor activity in mice. Some analogues in which the lactam rings are replaced by pyridine rings did not inhibit TMP synthase. The diethoxy analogue 25 is a 10-fold more potent inhibitor of TMP synthase than 1. The diacetoxy analogue 23 exhibits significant antitumor activity (T/C: 175%) against Meth-A fibrosarcoma in mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722687     DOI: 10.7164/antibiotics.42.727

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  Pseudonocardians A-C, new diazaanthraquinone derivatives from a deap-sea actinomycete Pseudonocardia sp. SCSIO 01299.

Authors:  Sumei Li; Xinpeng Tian; Siwen Niu; Wenjun Zhang; Yuchan Chen; Haibo Zhang; Xianwen Yang; Weimin Zhang; Wenjun Li; Si Zhang; Jianhua Ju; Changsheng Zhang
Journal:  Mar Drugs       Date:  2011-08-23       Impact factor: 6.085

2.  Diazaquinomycins E-G, novel diaza-anthracene analogs from a marine-derived Streptomyces sp.

Authors:  Michael W Mullowney; Eoghainín Ó hAinmhire; Anam Shaikh; Xiaomei Wei; Urszula Tanouye; Bernard D Santarsiero; Joanna E Burdette; Brian T Murphy
Journal:  Mar Drugs       Date:  2014-06-11       Impact factor: 5.118

3.  Total synthesis of diazaquinomycins H and J using double Knorr cyclization in the presence of triisopropylsilane.

Authors:  Allan M Prior; Dianqing Sun
Journal:  RSC Adv       Date:  2019-01-14       Impact factor: 4.036

4.  Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward Mycobacterium tuberculosis.

Authors:  Michael W Mullowney; Chang Hwa Hwang; Andrew G Newsome; Xiaomei Wei; Urszula Tanouye; Baojie Wan; Skylar Carlson; Nanthida Joy Barranis; EoghainínÓ hAinmhire; Wei-Lun Chen; Kalyanaraman Krishnamoorthy; John White; Rachel Blair; Hyunwoo Lee; Joanna E Burdette; Pradipsinh K Rathod; Tanya Parish; Sanghyun Cho; Scott G Franzblau; Brian T Murphy
Journal:  ACS Infect Dis       Date:  2015-03-11       Impact factor: 5.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.